Table 3.

Factors influencing the results of therapy measured by early virologic response (EVR = 1) or its lack (EVR = 0, necessity of re-therapy). ^a EVR was evaluated for 102 of 292 patients. Twenty-six individuals with EVR achieved also sustained virologic response (SVR), other patients are waiting 6 months after completion of treatment to be searched for SVR

Patients under therapy (n = 102)a	Success of therapy (EVR = 1)	Re-treatment (EVR = 0)
n	47	55
%	46.08	53.92
95 % CI	36.16; 56.23	43.77; 64.84
Duration of uncured infection (years)
Median	5	9
S n	3	5
95 % CI	4; 6	6; 12
OR 0.802	95 % CI 0.719; 0.877	p = 0.000033
Gender (female)
OR 2.395	95 % CI 0.94; 6.73	p = 0.072

OR odds ratio